Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

HIV Diagnostics Market Research Report, by Product (Consumables, Instruments and Software & Services), Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis and Tests for Viral Identification), End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Other) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2032


ID: MRFR/Pharma/8279-HCR | 140 Pages | Author: Rahul Gotadki| April 2024

Research Methodology on HIV Diagnostics Market


Introduction


The HIV Diagnostics Market is a multifaceted market of products and services that diagnose and monitor the Human Immunodeficiency Virus (HIV). The Market Research Future recently published a report which stated that the Global HIV Diagnostic Market is expected to reach an all-time high revenue during the forecast period from 2023-2030.


The report was prepared to analyze the current market trends and contributing factors that have triggered the growth of the HIV Diagnostics Market. The report focused on the market segments, leading players, potential investment opportunities, challenges and the outlook of the market. This research study provides an in-depth analysis of the market and provides detailed information about the various market segments based on product type, technology, end users, and regions.


Research Methodology


The research methodology adopted for this study is a combination of primary and secondary research. To begin with, an extensive literature review was conducted, which included research studies, reports and articles related to HIV diagnostics, market trends, technology developments, and regulatory updates. The objective of the review was to obtain an extensive overview of the global HIV diagnostic market from various perspectives.


The primary research involved conducting interviews with key stakeholders including market players, research institutes, and industry experts. The industry experts included those with expertise in product development and the healthcare markets with a particular focus on HIV diagnostics.


The interviews revealed information such as the current market size and growth trends, market shares of leading players, factors influencing the growth of the market, the competitive landscape, regulatory scenarios, and the current scenario of the HIV diagnostics industry. These insights were used to validate and corroborate the information obtained from the secondary research.


Data Collection


Data collection for the research was conducted using both primary and secondary methods. The primary data was gathered through interviews with industry experts, market participants, and healthcare professionals. The secondary data was sourced from various reliable sources such as international trade organizations, government websites, trade journals, white papers, and journals.


To obtain a clear and comprehensive picture of the market size, the analysis of the data collected was conducted using top-down and bottom-up techniques. The top-down approach was used to estimate the total market size based on the data collected from the interviews. The bottom-up approach was used to extrapolate the market estimates based on the country-level data collected from primary and secondary sources.


The collected data was then verified and validated using other industry-standard techniques such as statistical triangulation and cross-validation. The results of the data analysis were then used to make informed decisions on the market trends and to also draw inferences on the market dynamics.


Data Analysis


The data collected was analyzed using various qualitative and quantitative techniques such as qualitative and quantitative analysis, descriptive analysis, trend analysis, and comparative analysis. The qualitative analysis consisted of analyzing the data to gain an understanding of the market dynamics, market segments, and the strategies used by the market players. The quantitative analysis consisted of analyzing the data to gain an understanding of the current market size and potential growth trends in the future.


The market size was estimated using the market share analysis technique which was based on the sales of the products in the market. The data was further analyzed to infer the market trends and the competitive landscape in the industry. The insights were then used to form the basis for the primary research.


Conclusion


This research study provides a comprehensive analysis of the HIV Diagnostics Market and is based on both primary and secondary research. The research methodology adopted for this study included an extensive literature review, primary and secondary research, data collection, and data analysis. The results of the study show that the Global HIV Diagnostic Market is likely to experience significant growth in the coming years, led by the increasing number of HIV infections, advancements in diagnostic technology, and the increasing demand for rapid and accurate diagnostics.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

\Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global HIV Diagnostics Market, by Product

1.1.2. Global HIV Diagnostics Market, by Test Type

1.1.3. Global HIV Diagnostics Market, by End User

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Breakdown of Primary Respondents

3.5. Forecasting Test Types

3.6. Research Methodology for Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porterโ€™s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

5.3. Impact of COVID 19 on HIV Diagnostics Market

5.3.1. Impact on Market Value in 2023 and 2021

5.3.2. Clinical Trial Impact

5.3.3. Impact of Demand

5.3.4. Strategies to Overcome the challenges

6. GLOBAL HIV DIAGNOSTICS MARKET, BY PRODUCT

6.1. Overview

6.2. Consumables

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.2.1. Assays and Kits & Reagents

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.2.2. Other Consumables

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.3. Instruments

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.4. Software & Services

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7. GLOBAL HIV DIAGNOSTICS MARKET, BY TEST TYPE

7.1. Overview

7.2. Antibody Tests

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.1. HIV-1 Screening Test

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.1.1. Elisa

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.1.2. Rapid Tests

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.1.3. Home Access Dried Blood Spots

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.2. HIV-1 Antibody Confirmatory Tests

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.2.1. Western Blot Tests

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.2.2. Indirect Immunofluorescence Assays (IFA)

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.2.3. Line Immunoassay

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.2.4. Radio-Immunoprecipitation Assays

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.2.3. HIV-2 & Group O Diagnostic Tests

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.3. Viral Load Tests

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.4. CD4 Tests

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.5. Tests for Early Infant Diagnosis

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.6. Tests for Viral Identification

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

8. GLOBAL HIV DIAGNOSTICS MARKET, BY END USER

8.1. Overview

8.2. Diagnostic Laboratories

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

8.3. Hospitals

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

8.4. Blood Banks

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

8.5. Others

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

9. GLOBAL HIV DIAGNOSTICS MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitor Dashboard

10.3. Major Growth Strategy in the Global HIV Diagnostics Market

10.4. Competitive Benchmarking

10.5. The Leading Player in terms of Number of Developments in the Global HIV Diagnostics Market

10.6. Key Developments & Growth Strategies

10.6.1. New Product Launch/Service Deployment

10.6.2. Merger & Acquisition

10.6.3. Joint Ventures

10.7. Major Players Financial Matrix & Market Ratio

10.7.1. Sales & Operating Income 2019

10.7.2. Major Players R&D Expenditure 2019

11. COMPANY PROFILES

11.1. Siemens Healthineers (A Division of Siemens AG)

11.1.1. Company Overview

11.1.2. Products/Services Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Roche Diagnostics (Division of Hoffman La Roche Ltd.)

11.3. Abbott Laboratories

11.4. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

11.5. Thermo-Fisher Scientific Inc.

11.6. Merck KGaA

11.7. Becton, Dickinson & Company

11.8. Hologic Inc.

11.9. Alere Inc.

11.10. Bio-Rad Laboratories

11.11. Others

12. APPENDIX

12.1. References

12.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

๏‚ก ๏‚ก In section 11, only the top companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.

๏‚ก ๏‚ก Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.

LIST OF TABLES

TABLE 1 GLOBAL HIV DIAGNOSTICS MARKET SYNOPSIS, 2017โ€“2030

TABLE 2 GLOBAL HIV DIAGNOSTICS MARKET ESTIMATES & FORECAST, 2023โ€“2030 (USD MILLION)

TABLE 3 GLOBAL HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 4 GLOBAL HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 5 GLOBAL HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 6 GLOBAL HIV DIAGNOSTICS MARKET, BY REGION, 2023โ€“2030 (USD MILLION)

TABLE 7 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 8 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 9 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 10 US: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 11 US: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 12 US: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 13 CANADA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 14 CANADA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 15 CANADA: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 16 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 17 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 18 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 19 EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 20 EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 21 EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 22 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 23 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 24 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 25 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 26 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 27 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 28 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 29 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 30 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ€“2030 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ€“2030 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ€“2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HIV DIAGNOSTICS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HIV DIAGNOSTICS MARKET

FIGURE 4 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY PRODUCT, 2019 (%)

FIGURE 5 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY TEST TYPE, 2019 (%)

FIGURE 6 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY END USERS, 2019 (%)

FIGURE 7 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 8 AMERICAS: HIV DIAGNOSTICS MARKET SHARE BY REGION, 2019 (%)

FIGURE 9 NORTH AMERICA: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 10 EUROPE: HIV DIAGNOSTICS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 11 WESTERN EUROPE: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 12 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 13 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 14 GLOBAL HIV DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 15 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): KEY FINANCIALS

FIGURE 16 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): SEGMENTAL REVENUE

FIGURE 17 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): REGIONAL REVENUE

FIGURE 18 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.): KEY FINANCIALS

FIGURE 19 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.).: SEGMENTAL REVENUE

FIGURE 20 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.): REGIONAL REVENUE

FIGURE 21 ABBOTT LABORATORIES: KEY FINANCIALS

FIGURE 22 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 23 ABBOTT LABORATORIES: REGIONAL REVENUE

FIGURE 24 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): KEY FINANCIALS

FIGURE 25 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): SEGMENTAL REVENUE

FIGURE 26 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): REGIONAL REVENUE

FIGURE 27 THERMO-FISHER SCIENTIFIC INC.: KEY FINANCIALS

FIGURE 28 THERMO-FISHER SCIENTIFIC INC.: SEGMENTAL REVENUE

FIGURE 29 THERMO-FISHER SCIENTIFIC INC.: REGIONAL REVENUE

FIGURE 30 MERCK KGAA: KEY FINANCIALS

FIGURE 31 MERCK KGAA: SEGMENTAL REVENUE

FIGURE 32 MERCK KGAA: REGIONAL REVENUE

FIGURE 33 BECTON, DICKINSON & COMPANY: KEY FINANCIALS

FIGURE 34 BECTON, DICKINSON & COMPANY: SEGMENTAL REVENUE

FIGURE 35 BECTON, DICKINSON & COMPANY: REGIONAL REVENUE

FIGURE 36 HOLOGIC INC.: KEY FINANCIALS

FIGURE 37 HOLOGIC INC.: SEGMENTAL REVENUE

FIGURE 38 HOLOGIC INC.: REGIONAL REVENUE

FIGURE 39 ALERE INC.: KEY FINANCIALS

FIGURE 40 ALERE INC.: SEGMENTAL REVENUE

FIGURE 41 ALERE INC.: REGIONAL REVENUE

FIGURE 42 BIO-RAD LABORATORIES.: KEY FINANCIALS

FIGURE 43 BIO-RAD LABORATORIES.: SEGMENTAL REVENUE

FIGURE 44 BIO-RAD LABORATORIES.: REGIONAL REVENUE

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.